183 related articles for article (PubMed ID: 37749171)
1. Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma.
Zeng J; Zhu P; Tang Y; Zhang C; Ye C; Cheng S; Tian K; Yang B; Zeng W; Liu Y; Xian Z; Yu Y
Sci Rep; 2023 Sep; 13(1):16055. PubMed ID: 37749171
[TBL] [Abstract][Full Text] [Related]
2. Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy.
Ma J; Kang Z; Yang G; Wang X; Si M; Wang Y; Li G; Bai S; Zeng F; Li M; Wang Z; Wang L; Xu W
Front Biosci (Landmark Ed); 2023 Dec; 28(12):334. PubMed ID: 38179741
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
[TBL] [Abstract][Full Text] [Related]
4. Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients.
Chen J; Jiang R; Guan W; Cao Q; Tian Y; Dong K; Pan X; Cui X
Int J Med Sci; 2024; 21(3):496-507. PubMed ID: 38250606
[No Abstract] [Full Text] [Related]
5. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY
Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database.
Gan Y; Zhang Z; Wang X; Li A; Fan Y; Zhang Q
J Healthc Eng; 2022; 2022():8224618. PubMed ID: 36349258
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
PeerJ; 2023; 11():e14691. PubMed ID: 36650832
[TBL] [Abstract][Full Text] [Related]
8. A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy.
Wang Y; Liu J; Zhang L; Li Y
Dis Markers; 2022; 2022():6402599. PubMed ID: 35845137
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
Front Genet; 2022; 13():905051. PubMed ID: 35846134
[TBL] [Abstract][Full Text] [Related]
10. A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma.
Li Z; Xia Z; Yu Y; Cai L; Jian W; Wang T; Xue W; Wang X; Wang B; Zhang P; Yao W; Zhang C; Wang C
BMC Med Genomics; 2022 Sep; 15(1):204. PubMed ID: 36163033
[TBL] [Abstract][Full Text] [Related]
11. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
Front Immunol; 2022; 13():934243. PubMed ID: 36189255
[TBL] [Abstract][Full Text] [Related]
13. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
[TBL] [Abstract][Full Text] [Related]
14. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a kidney renal clear cell carcinoma prognostic model relying on pyroptosis-related LncRNAs-A multidimensional comprehensive bioinformatics exploration.
Liu C; Dai S; Geng H; Jiang Z; Teng X; Liu K; Tuo Z; Peng L; Yang C; Bi L
Eur J Med Res; 2023 Sep; 28(1):341. PubMed ID: 37700389
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCC.
Li Y; Maimaiti M; Yang B; Lu Z; Zheng Q; Lin Y; Luo W; Wang R; Ding L; Wang H; Chen X; Xu Z; Wang M; Li G; Gao L
Cell Signal; 2023 Nov; 111():110888. PubMed ID: 37717714
[TBL] [Abstract][Full Text] [Related]
19. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
